Semaglutide Peptide Pen: What It Is, How It Works, and What to Expect

Semaglutide is a synthetic peptide: it binds GLP-1 receptors in the brain and gut, reducing appetite and slowing the rate at which food leaves the stomach.
The pre-filled Wegovy pen delivers a fixed weekly dose (no drawing up, no measuring) and the needle is covered automatically on most formats.
Each pen contains four weekly doses; the prescribing schedule starts at 0.25 mg and is titrated upward by the prescriber over several months.
Storage matters: pens must be refrigerated between 2°C and 8°C; once in use, the exact room-temperature window is set out in the patient information leaflet, not a round number to memorise.

Semaglutide is a peptide — a short chain of amino acids — engineered to mimic the GLP-1 hormone your gut releases after eating. In its pen form, it is injected once a week under the skin and licensed in the UK as Wegovy for weight management. It is a prescription-only medicine; a clinician assesses suitability before any supply. The NHS medicines page on semaglutide explains the pharmacology plainly if you want to go deeper before your first consultation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Using a semaglutide peptide pen correctly: a step-by-step walkthrough

Step 1, Prepare your pen and pick your injection site

Before anything else, take the pen out of the fridge roughly 30 minutes before you plan to inject. Cold medicine can sting more on the way in, and letting it reach room temperature is a small habit that makes a real difference. While it warms, check the cartridge window: the liquid should be clear and colourless. If it looks cloudy, discoloured, or carries visible particles, do not use it.

Semaglutide can be injected into the abdomen (avoiding the two-inch ring around the navel), the front of the thigh, or the outer upper arm. Rotate sites each week, injecting repeatedly into exactly the same spot can cause the tissue to harden over time, which affects how the medicine is absorbed. A simple way to keep track: write the site on your phone calendar alongside the injection day.

Clean the chosen site with an alcohol swab and let it dry fully before injecting. Wet skin slightly increases the sting; 10 seconds of air-drying costs nothing. Single-use alcohol swabs are an easy supply to keep topped up alongside your pens.

Step 2, Inject and discard the needle safely

Remove the pen cap, attach a fresh needle if your pen format requires one (the patient information leaflet specifies this), and dial to the prescribed dose. If you want a closer look at the device before you start, our semaglutide pen page walks through each part of the pen and what it does. Press the pen firmly against the skin (you do not need to pinch) and hold the button down for the full count specified in the leaflet. A slow, deliberate press reduces the chance of liquid tracking back up the needle track.

After the injection, keep the pen in contact with the skin for a few seconds before withdrawing. This lets the full dose disperse. Never rub the site afterwards; it can cause the medicine to disperse unevenly.

Used needles are sharps waste. They go straight into a puncture-resistant sharps container, capped immediately after removal. The pen itself is not a sharp, but once all four doses are used it should be disposed of according to your local pharmacy's guidance. For a broader picture of how the semaglutide injection process compares across pen formats, that page covers the full landscape.

Step 3, Store the pen correctly between doses

Wegovy pens live in the fridge. The correct range is 2°C to 8°C; most domestic fridge doors sit slightly warmer than the main shelf, so a middle shelf is a safer spot. Do not freeze them, and do not leave them in a car or by a sunny window.

Whether an opened pen can be used at room temperature for a short period (and for exactly how long) is answered precisely in the patient information leaflet that comes with your treatment. That figure can change between product batches and pen formats, so quoting a number here would be less reliable than reading it from your own box. The Wegovy refrigeration page covers the storage rules in full, including what to do if the pen has been left out longer than intended.

A useful one-minute habit: each time you put the pen back in the fridge, check the expiry date printed on the label. Pens that have passed their date should not be used regardless of appearance.

Side effects to be aware of from the semaglutide peptide injection

The most commonly reported effects are gastrointestinal: nausea, loose stools, constipation, and indigestion appear most often in the days after a dose increase and typically ease as the body adjusts. Eating smaller portions and avoiding high-fat meals around injection day helps for many people. Fatigue and mild headache are also reported, especially early on.

A small number of people experience more serious reactions. Severe stomach pain that travels to the back, with or without vomiting, can signal pancreatitis and needs urgent medical assessment. The MHRA issued a Drug Safety Update in January 2026 specifically flagging acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. Gallbladder problems, signs of a significant allergic reaction, and dehydration from persistent vomiting are also reasons to seek help promptly rather than waiting for the next prescription review.

If you notice anything unexpected, you can report it directly through the MHRA Yellow Card scheme, this applies to any suspected side effect from any medicine, including ones already listed in the leaflet. Our aftercare team is also available seven days a week if something concerns you between reviews. The Wegovy overview page sets out the full side-effect profile and what to do at each stage.

Semaglutide is not licensed for use during pregnancy, while breastfeeding, or when actively trying to conceive. It is not licensed for under-18s. For women using oral contraceptives, discuss with your prescriber whether an additional method is advisable, particularly around dose changes. These are decisions made individually at consultation, not general rules with a single answer.

Thinking about whether the semaglutide peptide pen is right for you? The free consultation with our prescribers is the right starting point. For context on what private weight-loss treatment costs across the UK, the weight-loss overview has an honest breakdown. And if you would like a practical guide covering how to inject semaglutide safely and confidently, that page takes you through the full technique step by step, or if you are curious how the pen compares across dose formats, the semaglutide pens page runs through the options.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions